Chronic cough, defined as a cough persisting beyond eight weeks, poses a significant diagnostic and therapeutic challenge in clinical practice. It can be a symptom of an underlying condition or a disease entity in itself. This article aims to provide a comprehensive approach to its management.
Identifying the cause is the first step in managing chronic cough. Common etiologies include gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS) secondary to rhinosinus conditions. Less common causes, such as lung cancer, should also be considered in high-risk patients. A detailed history, physical examination, and appropriate diagnostic tests are crucial in this phase.
Treatment should be directed at the underlying cause. For example, proton pump inhibitors may be beneficial in GERD-associated cough, while inhaled corticosteroids are the treatment of choice for asthma-related cough. In cases where chronic cough is a disease in itself, centrally acting agents like gabapentin and amitriptyline have shown efficacy.
Despite a comprehensive approach, a subset of patients remains with idiopathic chronic cough. In these cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be beneficial. Future research should focus on understanding the pathophysiology of chronic cough better and developing targeted therapies.
Managing chronic cough requires a systematic approach to identify the underlying cause and provide targeted treatment. Despite current strategies, chronic cough remains a therapeutic challenge, underscoring the need for continued research and multidisciplinary collaboration.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation